ARNA +29%/AH on phase-2 data in PAH: http://www.prnewswire.com/news-releases/arena-pharmaceuticals-reports-positive-topline-phase-2-results-for-ralinepag-in-patients-with-pulmonary-arterial-hypertension-300485483.html CC at 4:30pm ET.